PhoenixD(@Geogeek0) 's Twitter Profile Photo

Factoris of Maharashtra

Reliance Life Sciences
📍MIDC Dindori, Nashik

Reliance Life Sciences is setting up a new greenfield Research and manufacturing facility for Plasma Protein, Biopharmaceuticals and Vaccines.

Status : U/C
Area : 160 Acres
Investment : 2200 Crores

Factoris of Maharashtra  #Fo_MH

Reliance Life Sciences 
📍MIDC Dindori, Nashik

Reliance Life Sciences is setting up a new greenfield Research and manufacturing facility for Plasma Protein, Biopharmaceuticals and Vaccines.

Status : U/C
Area : 160 Acres
Investment : 2200 Crores
account_circle
Raghav Wadhwa(@raghavwadhwa) 's Twitter Profile Photo

✍️Wockhardt Ltd:
Engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals.

🔹M Cap: ₹8,406 Cr
🔹FIIs Holding 5.49%
🔹Change in FIIs Holding 🔼1.31%
🔹DIIs Holding 4.82%
🔹Change in DIIs Holding🔼4.52%

✍️Wockhardt Ltd:
Engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals.

🔹M Cap: ₹8,406 Cr
🔹FIIs Holding 5.49%
🔹Change in FIIs Holding 🔼1.31%
🔹DIIs Holding 4.82%
🔹Change in DIIs Holding🔼4.52%
account_circle
3PBIOVIAN(@3PBiovian) 's Twitter Profile Photo

The ASCGT Baltimore is THE Cell & Gene Therapy event of the year!
Schedule a meeting with us to discover how our viral vectors manufacturing capabilities can enhance your gene therapy development journey. 🚀

account_circle
3PBIOVIAN(@3PBiovian) 's Twitter Profile Photo

Hey, San Diego!
We're here at the Festival of Biologics, ready to chat about how we can make your biologics journey smoother.
Drop by booth #440 to meet Jayme Tortorici and Tim Cinq Mars.

account_circle
Shay Boloor(@StockSavvyShay) 's Twitter Profile Photo

5. $VKTX | Viking Therapeutics

• Current Valuation $63.42 | $6.7B MC
• Industry | Biopharmaceuticals
• Balance Sheet | $362M Cash, $1M Debt

• Competitive Advantage: They're making strides in the treatment of metabolic and endocrine disorders with its novel therapeutic

5. $VKTX | Viking Therapeutics

• Current Valuation $63.42 | $6.7B MC
• Industry | Biopharmaceuticals
• Balance Sheet | $362M Cash, $1M Debt

• Competitive Advantage: They're making strides in the treatment of metabolic and endocrine disorders with its novel therapeutic
account_circle
AoI Ventures(@aoiventures) 's Twitter Profile Photo

Zydus Life: Sentynl Therapeutics (US-based biopharma company wholly-owned by Zydus Lifesciences) announces global acquisition of Zokinvy® (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from Biopharmaceuticals

Zydus Life: Sentynl Therapeutics (US-based biopharma company wholly-owned by Zydus Lifesciences) announces global acquisition of Zokinvy® (Lonafarnib) for treatment of Hutchinson-Gilford Progeria Syndrome from #Eiger Biopharmaceuticals
account_circle
Sam Blackman(@drsam) 's Twitter Profile Photo

Proud of the hard work from the Day One Biopharmaceuticals teams and the broader pediatric oncology community to make this achievement possible! We did it!

account_circle
NIPER SAS Nagar (Mohali)(@NIPER_SAS_NAGAR) 's Twitter Profile Photo

Prof. Pande elaborated on the recent trends in the development of Antibody-based products and encouraged the students to become entrepreneurs in the field of Biopharmaceuticals.

Prof. Pande elaborated on the recent trends in the development of Antibody-based products and encouraged the students to become entrepreneurs in the field of Biopharmaceuticals.
account_circle
METTLER TOLEDO(@mettlertoledo) 's Twitter Profile Photo

Accurate measurement boosts bioreactor yield. Adaptable processes for biopharmaceuticals. METTLER TOLEDO sensors for multiple reactors. Stay informed on , & . Get our guide now!🔔
okt.to/PJtGXr

Accurate measurement boosts bioreactor yield. Adaptable processes for biopharmaceuticals. METTLER TOLEDO sensors for multiple reactors. Stay informed on #Bioprocessing, #Bioreactors & #ProcessAnalytics. Get our guide now!🔔 
okt.to/PJtGXr
account_circle
Biocon Academy(@BioconAcademy) 's Twitter Profile Photo

Enhance your skills with the Program in .
Learn how Biotech discovers, develops, and brings biopharmaceuticals to the market.
Register today: bit.ly/3k19mhz

Enhance your skills with the #BioconKGICertificate Program in #Biosciences. 
Learn how Biotech discovers, develops, and brings biopharmaceuticals to the market. 
Register today: bit.ly/3k19mhz  
#BioconKGICertificate #AdmissionsOpen
account_circle
JS Chanan(@jschanan) 's Twitter Profile Photo

Zydus Lifesciences:

Sentynl Therapeutics Announces Global Acquisition Of Zokinvy (Lonafarnib) For Treatment Of Hutchinson-Gilford Progeria Syndrome From Eiger Biopharmaceuticals

Zydus Lifesciences: 

Sentynl Therapeutics Announces Global Acquisition Of Zokinvy (Lonafarnib) For Treatment Of Hutchinson-Gilford Progeria Syndrome From Eiger Biopharmaceuticals
account_circle
Provectus Biopharmaceuticals, Inc.(@ProvectusBio) 's Twitter Profile Photo

$PVCT Announces Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting globenewswire.com/news-release/2… Sodium

account_circle
PenkeTrading.com(@PenkeTrading) 's Twitter Profile Photo

I found you a Three Black Crows Candle Pattern on the daily chart of XTL Biopharmaceuticals Ltd.

$h2k2

penketrading.com/symbols/H2K2.F/

I found you a Three Black Crows Candle Pattern on the daily chart of XTL Biopharmaceuticals Ltd.

 $h2k2 #h2k2 #bearish #f #xfra

penketrading.com/symbols/H2K2.F/
account_circle
居残り佐平次🍥(@inokori_3814) 's Twitter Profile Photo

4563   アンジェス

Eiger BioPharmaceuticals, Inc.に関するお知らせ
( ・ㅂ・)つpost.tokyoipo.com/tdnet/20240412…

4563   アンジェス

Eiger BioPharmaceuticals, Inc.に関するお知らせ
(  ・ㅂ・)つpost.tokyoipo.com/tdnet/20240412…
account_circle
American Brain Tumor Association(@theABTA) 's Twitter Profile Photo

A new oral therapeutic for children diagnosed with pediatric low-grade glioma (pLGG) has received approval by the Food and Drug Administration!

Click below to view the press release from the manufacturer, Day One Biopharmaceuticals.

bit.ly/3UoSRdN

A new oral therapeutic for children diagnosed with pediatric low-grade glioma (pLGG) has received approval by the Food and Drug Administration! 

Click below to view the press release from the manufacturer, Day One Biopharmaceuticals.

bit.ly/3UoSRdN
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

This past weekend, some of our Denver-based Day One team members came together to participate in the local 2nd Annual Tumor Trot. Supporting the fight against childhood brain tumors is a cause we deeply believe in.

This past weekend, some of our Denver-based Day One team members came together to participate in the local 2nd Annual Tumor Trot. Supporting the fight against childhood brain tumors is a cause we deeply believe in.

#BrainTumorAwareness #BTAM #GoGrayinMay
account_circle
$PVCT(@Ablate_Cancer) 's Twitter Profile Photo

Corporate Presentation - Provectus Biopharmaceuticals, Inc.

Why invest in Provectus Biopharmaceuticals?

Potential PV-10 treatments target total patient populations of more than $125+ billion in annual sales.

-10 $PVCT provectusbio.com/corporate-pres…

account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

’s US arm Sentynl Therapeutics acquires worldwide proprietary rights to Zokinvy at net base price of $45 million from US-based Eiger Biopharmaceuticals

Alert | Zokinvy is approved for the treatment of a collection of ultra-rare, fatal, genetic premature aging diseases

#ZydusLife’s US arm Sentynl Therapeutics acquires worldwide proprietary rights to Zokinvy at net base price of $45 million from US-based Eiger Biopharmaceuticals

Alert | Zokinvy is approved for the treatment of a collection of ultra-rare, fatal, genetic premature aging diseases
account_circle